BIOMAT Database Logo BIOMAT Database Logo

Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonists. 2000

N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
Department of Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-5400, USA. murugesan@bms.com

The synthesis and structure-activity relationship (SAR) studies of a series of 4'-oxazolyl-N-(3,4-dimethyl-5-isoxazolyl)[1, 1'-biphenyl]-2-sulfonamide derivatives as endothelin-A (ET(A)) receptor antagonists are described. The data reveal a remarkable improvement in potency and metabolic stability when the 4'-position of the biphenylsulfonamide is substituted with an oxazole ring. Additional 2'-substitution of an acylaminomethyl group further increased the binding activity and provided one of the first subnanomolar ET(A)-selective antagonists in the biphenylsulfonamide series (17, ET(A) K(i) = 0.2 nM). Among the compounds described, 3 (N-(3,4-dimethyl-5-isoxazolyl)-4'-(2-oxazolyl)[1, 1'-biphenyl]-2-sulfonamide; BMS-193884) had the optimum pharmacological profile and was therefore selected as a clinical candidate for studies in congestive heart failure.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002339 Carotid Arteries Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery. Arteries, Carotid,Artery, Carotid,Carotid Artery

Related Publications

N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
1,3-Disubstituted-2-carboxy quinolones: highly potent and selective endothelin A receptor antagonists.
July 2000, Bioorganic & medicinal chemistry letters,
N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonists.
November 2001, Journal of medicinal chemistry,
N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists.
June 2002, Journal of medicinal chemistry,
N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546).
August 1998, Journal of medicinal chemistry,
N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
Discovery of a new class of potent, selective, and orally active prostaglandin D2 receptor antagonists.
October 2004, Bioorganic & medicinal chemistry,
N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.
December 2005, Journal of medicinal chemistry,
N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
Isoindolines: a new series of potent and selective endothelin-A receptor antagonists.
July 2001, Bioorganic & medicinal chemistry letters,
N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist.
July 1998, Bioorganic & medicinal chemistry letters,
N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
New highly potent and selective adenosine A(3) receptor antagonists.
January 2004, Current topics in medicinal chemistry,
N Murugesan, and Z Gu, and P D Stein, and S Spergel, and A Mathur, and L Leith, and E C Liu, and R Zhang, and E Bird, and T Waldron, and A Marino, and R A Morrison, and M L Webb, and S Moreland, and J C Barrish
Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists.
November 2013, ACS medicinal chemistry letters,
Copied contents to your clipboard!